Market Cap 7.09B
Revenue (ttm) 290.52M
Net Income (ttm) 89.16M
EPS (ttm) N/A
PE Ratio 37.00
Forward PE 39.93
Profit Margin 30.69%
Debt to Equity Ratio 0.00
Volume 334,000
Avg Vol 305,150
Day's Range N/A - N/A
Shares Out 29.00M
Stochastic %K 89%
Beta 0.48
Analysts Strong Sell
Price Target $223.89

Company Profile

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treati...

Industry: Biotechnology
Sector: Healthcare
Phone: 412 586 5830
Address:
2100 Wharton Street, Suite 701, Pittsburgh, United States
Doozio
Doozio Dec. 13 at 3:04 PM
$KRYS leaders lead and $ASND ed thru da $$$ 🐒🍌🧠⏰♾️
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 12 at 12:06 AM
Actionable Trade Alert for $KRYS: Market Context: $KRYS is currently trading at $245.57, near its 60-day high of $245.78, indicating strong bullish momentum. The RSI at 92.37 suggests the stock is overbought, which may lead to a pullback. However, the overall trend remains bullish given the strong performance above the 30-day MA of $211.93 and the 50-day MA of $201.98. Directional Bias: The stock shows a bullish bias, but caution is warranted due to the high RSI. A pullback could be expected before further upward movement. Trade Plan: - Suggested Entry: $245.00 - Stop Loss: $230.00 (6.2% risk) - Take Profit Targets: - Target 1: $255.00 (3.8% gain) - Target 2: $265.00 (7.9% gain) - Target 3: $287.00 (17% gain) This trade plan allows for a balanced risk-reward ratio while capitalizing on potential upward movement. Monitor the RSI and adjust positions accordingly. https://privateprofiteers.com
0 · Reply
IslaBoost
IslaBoost Dec. 11 at 1:06 PM
$KRYS genetic and rare disease focus, big binary moves around data and approvals are the rule 💊
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 4:09 AM
Actionable Trade Alert for $KRYS: Market Context: $KRYS is currently trading at $234.64, showing strong momentum but an extremely high RSI of 88.71, indicating overbought conditions. The stock is above its 30-day (MA30) and 50-day (MA50) moving averages, which are at $208.25 and $199.39 respectively. The recent high of $241.65 suggests potential resistance. Directional Bias: The high RSI signals a potential pullback, but the stock remains strong above key moving averages, indicating bullish sentiment. Trade Plan: - Suggested Entry: $234.64 - Stop Loss: $225.00 (below recent support) - Take Profit Targets: 1. $240.00 (2.3% gain) 2. $245.00 (4.4% gain) 3. $275.00 (17.2% gain) With a potential ROI of over 17% on the third target, this trade aligns with the bullish trend while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 8 at 11:58 PM
Actionable Trade Alert for $KRYS: Market Context: $KRYS is currently trading at $230.57, exhibiting strong momentum with an RSI of 74.79, indicating overbought conditions. The price is above both the 30-day MA (206.64) and the 50-day MA (198.16), suggesting bullish sentiment. However, the high RSI signals potential for a pullback. Directional Bias: Given the high RSI and proximity to the 60D high of $241.65, a cautious approach is warranted. The price has room to move higher, but a correction could occur. Trade Plan: - Suggested Entry: $230.57 - Stop Loss: $220.00 (risking $10.57) - Take Profit Targets: 1. TP1: $240.00 (4.5% gain) 2. TP2: $250.00 (8.4% gain) 3. TP3: $270.00 (17% gain) This plan offers a balanced risk-reward profile, with a potential 17% ROI at TP3. Monitor the price action closely for signs of reversal. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 2:57 AM
Actionable Trade Alert for $KRYS: Market Context: $KRYS is currently trading at $221.96, near its 60D high of $222.66, indicating strong bullish momentum. The RSI at 78.56 suggests that the stock is overbought, which could lead to a pullback. However, the upward trend is supported by the MA30 at $203.57 and MA50 at $195.45, indicating a strong bullish bias in the medium term. Directional Bias: Bullish, but watch for potential short-term corrections due to the high RSI. Trade Plan: - Suggested Entry: $221.96 - Stop Loss: $215.00 (approx. 3.6% below entry) - Take Profit Targets: 1. TP1: $225.00 (1.4% ROI) 2. TP2: $230.00 (3.6% ROI) 3. TP3: $260.00 (17% ROI) Given the current metrics and market conditions, this trade plan offers a solid risk-to-reward ratio. Monitor RSI and price action closely for adjustments. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 10:32 PM
Actionable Trade Alert for $KRYS: Market Context: $KRYS is currently trading at $221.96, near its 60D high of $222.66, indicating strong bullish momentum. The RSI at 78.56 suggests that the stock is overbought, which could lead to a pullback. However, the upward trend is supported by the MA30 at $203.57 and MA50 at $195.45, indicating a strong bullish bias in the medium term. Directional Bias: Bullish, but watch for potential short-term corrections due to the high RSI. Trade Plan: - Suggested Entry: $221.96 - Stop Loss: $215.00 (approx. 3.6% below entry) - Take Profit Targets: 1. TP1: $225.00 (1.4% ROI) 2. TP2: $230.00 (3.6% ROI) 3. TP3: $260.00 (17% ROI) Given the current metrics and market conditions, this trade plan offers a solid risk-to-reward ratio. Monitor RSI and price action closely for adjustments. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
ZManicItalian
ZManicItalian Dec. 5 at 9:00 PM
$KRYS 🍻🐂
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 5 at 8:20 PM
$KRYS Current Stock Price: $230.20 Contracts to trade: $230 KRYS Dec 19 2025 Call Entry: $6.30 Exit: $10.49 ROI: 67% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Quantumup
Quantumup Dec. 5 at 11:52 AM
BTIG🏁 $PVLA at a Buy rating and a $167 price target. Craig-Hallum y'day🏁at a Buy rating and a $175 price target. Clear Street y'day🏁at a Buy rating and a $200 PT. $SLNO $KRYS Here's what the Analysts had to say in their initiation reports:
0 · Reply
Latest News on KRYS
Krystal Biotech, Inc. (KRYS) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 11:46 AM EST - 5 weeks ago

Krystal Biotech, Inc. (KRYS) Q3 2025 Earnings Call Transcript


Krystal Biotech, Inc. (KRYS) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 12:42 PM EDT - 4 months ago

Krystal Biotech, Inc. (KRYS) Q2 2025 Earnings Call Transcript


Krystal (KRYS) Q2 Profit Jumps 143%

Aug 4, 2025, 8:43 AM EDT - 4 months ago

Krystal (KRYS) Q2 Profit Jumps 143%


Krystal Biotech, Inc. (KRYS) Q1 2025 Earnings Call Transcript

May 6, 2025, 2:43 PM EDT - 7 months ago

Krystal Biotech, Inc. (KRYS) Q1 2025 Earnings Call Transcript


Krystal Biotech to Present at Upcoming Scientific Conferences

Apr 24, 2025, 8:00 AM EDT - 8 months ago

Krystal Biotech to Present at Upcoming Scientific Conferences


Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer

Apr 7, 2025, 4:30 PM EDT - 8 months ago

Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer


Krystal Biotech, Inc. (KRYS) Q4 2024 Earnings Call Transcript

Feb 19, 2025, 11:43 AM EST - 10 months ago

Krystal Biotech, Inc. (KRYS) Q4 2024 Earnings Call Transcript


Krystal Biotech to Present at Upcoming Investor Conferences

Nov 27, 2024, 7:00 AM EST - 1 year ago

Krystal Biotech to Present at Upcoming Investor Conferences


Krystal Biotech, Inc. (KRYS) Q1 2024 Earnings Call Transcript

May 6, 2024, 11:44 AM EDT - 1 year ago

Krystal Biotech, Inc. (KRYS) Q1 2024 Earnings Call Transcript


Doozio
Doozio Dec. 13 at 3:04 PM
$KRYS leaders lead and $ASND ed thru da $$$ 🐒🍌🧠⏰♾️
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 12 at 12:06 AM
Actionable Trade Alert for $KRYS: Market Context: $KRYS is currently trading at $245.57, near its 60-day high of $245.78, indicating strong bullish momentum. The RSI at 92.37 suggests the stock is overbought, which may lead to a pullback. However, the overall trend remains bullish given the strong performance above the 30-day MA of $211.93 and the 50-day MA of $201.98. Directional Bias: The stock shows a bullish bias, but caution is warranted due to the high RSI. A pullback could be expected before further upward movement. Trade Plan: - Suggested Entry: $245.00 - Stop Loss: $230.00 (6.2% risk) - Take Profit Targets: - Target 1: $255.00 (3.8% gain) - Target 2: $265.00 (7.9% gain) - Target 3: $287.00 (17% gain) This trade plan allows for a balanced risk-reward ratio while capitalizing on potential upward movement. Monitor the RSI and adjust positions accordingly. https://privateprofiteers.com
0 · Reply
IslaBoost
IslaBoost Dec. 11 at 1:06 PM
$KRYS genetic and rare disease focus, big binary moves around data and approvals are the rule 💊
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 4:09 AM
Actionable Trade Alert for $KRYS: Market Context: $KRYS is currently trading at $234.64, showing strong momentum but an extremely high RSI of 88.71, indicating overbought conditions. The stock is above its 30-day (MA30) and 50-day (MA50) moving averages, which are at $208.25 and $199.39 respectively. The recent high of $241.65 suggests potential resistance. Directional Bias: The high RSI signals a potential pullback, but the stock remains strong above key moving averages, indicating bullish sentiment. Trade Plan: - Suggested Entry: $234.64 - Stop Loss: $225.00 (below recent support) - Take Profit Targets: 1. $240.00 (2.3% gain) 2. $245.00 (4.4% gain) 3. $275.00 (17.2% gain) With a potential ROI of over 17% on the third target, this trade aligns with the bullish trend while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 8 at 11:58 PM
Actionable Trade Alert for $KRYS: Market Context: $KRYS is currently trading at $230.57, exhibiting strong momentum with an RSI of 74.79, indicating overbought conditions. The price is above both the 30-day MA (206.64) and the 50-day MA (198.16), suggesting bullish sentiment. However, the high RSI signals potential for a pullback. Directional Bias: Given the high RSI and proximity to the 60D high of $241.65, a cautious approach is warranted. The price has room to move higher, but a correction could occur. Trade Plan: - Suggested Entry: $230.57 - Stop Loss: $220.00 (risking $10.57) - Take Profit Targets: 1. TP1: $240.00 (4.5% gain) 2. TP2: $250.00 (8.4% gain) 3. TP3: $270.00 (17% gain) This plan offers a balanced risk-reward profile, with a potential 17% ROI at TP3. Monitor the price action closely for signs of reversal. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 2:57 AM
Actionable Trade Alert for $KRYS: Market Context: $KRYS is currently trading at $221.96, near its 60D high of $222.66, indicating strong bullish momentum. The RSI at 78.56 suggests that the stock is overbought, which could lead to a pullback. However, the upward trend is supported by the MA30 at $203.57 and MA50 at $195.45, indicating a strong bullish bias in the medium term. Directional Bias: Bullish, but watch for potential short-term corrections due to the high RSI. Trade Plan: - Suggested Entry: $221.96 - Stop Loss: $215.00 (approx. 3.6% below entry) - Take Profit Targets: 1. TP1: $225.00 (1.4% ROI) 2. TP2: $230.00 (3.6% ROI) 3. TP3: $260.00 (17% ROI) Given the current metrics and market conditions, this trade plan offers a solid risk-to-reward ratio. Monitor RSI and price action closely for adjustments. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 10:32 PM
Actionable Trade Alert for $KRYS: Market Context: $KRYS is currently trading at $221.96, near its 60D high of $222.66, indicating strong bullish momentum. The RSI at 78.56 suggests that the stock is overbought, which could lead to a pullback. However, the upward trend is supported by the MA30 at $203.57 and MA50 at $195.45, indicating a strong bullish bias in the medium term. Directional Bias: Bullish, but watch for potential short-term corrections due to the high RSI. Trade Plan: - Suggested Entry: $221.96 - Stop Loss: $215.00 (approx. 3.6% below entry) - Take Profit Targets: 1. TP1: $225.00 (1.4% ROI) 2. TP2: $230.00 (3.6% ROI) 3. TP3: $260.00 (17% ROI) Given the current metrics and market conditions, this trade plan offers a solid risk-to-reward ratio. Monitor RSI and price action closely for adjustments. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
ZManicItalian
ZManicItalian Dec. 5 at 9:00 PM
$KRYS 🍻🐂
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 5 at 8:20 PM
$KRYS Current Stock Price: $230.20 Contracts to trade: $230 KRYS Dec 19 2025 Call Entry: $6.30 Exit: $10.49 ROI: 67% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Quantumup
Quantumup Dec. 5 at 11:52 AM
BTIG🏁 $PVLA at a Buy rating and a $167 price target. Craig-Hallum y'day🏁at a Buy rating and a $175 price target. Clear Street y'day🏁at a Buy rating and a $200 PT. $SLNO $KRYS Here's what the Analysts had to say in their initiation reports:
0 · Reply
macroaxis
macroaxis Dec. 3 at 12:25 AM
$KRYS - Krystal Options Alert: Put Open Interest Drops to 282.0 – Watch for Potential Volatility https://www.macroaxis.com/stock-options/KRYS/Krystal-Biotech?utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
Ortho91
Ortho91 Nov. 28 at 12:12 PM
$KRYS rock on 🤘🏻
0 · Reply
PolycarpFX
PolycarpFX Nov. 24 at 10:11 PM
Red Mile Group's latest holdings, one of the best biotech firms in the world I’ll be releasing my quarterly Biotech Report this week via my newsletter. $SRRK $KRYS $ZYME $IDYA
0 · Reply
Ortho91
Ortho91 Nov. 22 at 10:47 PM
$KRYS shorts are down 48% since 9/25🤣
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 22 at 9:27 PM
0 · Reply
Swifty_11
Swifty_11 Nov. 22 at 1:45 AM
$KRYS https://www.gurufocus.com/news/3218711/krystal-biotech-krys-secures-fda-orphan-status-for-haileyhailey-treatment
0 · Reply
ZManicItalian
ZManicItalian Nov. 21 at 5:48 PM
$KRYS 🍻 to all the long time bulls here. Special shout out to @JFais for writing on this company back around the IPO!
1 · Reply
SweepCastApp
SweepCastApp Nov. 17 at 11:20 PM
$KRYS: Unusual Options Activity Alerted CALL flow observed 5x contracts at Strike price of $145 Exp on 11/21/2025 with Premium of $32K and showing BEARISH Sentiment
0 · Reply
Ortho91
Ortho91 Nov. 15 at 1:18 AM
$KRYS 🔥🔥🔥 This is going to be dangerously to continue shorting!!! Stay strong and tune out
0 · Reply
Quantumup
Quantumup Nov. 12 at 7:43 PM
Stifel trimmed⬇️ $ABEO's PT to $19 from $20 and reiterated at a Buy rating. $KRYS Here's what Stifel had to say in its note:
0 · Reply
ZManicItalian
ZManicItalian Nov. 12 at 5:02 PM
$KRYS 🤑🤙
0 · Reply
MaverikIT
MaverikIT Nov. 12 at 3:09 PM
0 · Reply